Brief: AngioDynamics To Sell Dialysis Product Portfolio, Biosentry Product For $100 Mln
June 8 (Reuters) - AngioDynamics Inc ANGO.O :
* ANGIODYNAMICS ANNOUNCES SALE OF DIALYSIS PRODUCT PORTFOLIO
AND
BIOSENTRY PRODUCT TO MERIT MEDICAL SYSTEMS FOR $100 MILLION
* ANGIODYNAMICS INC - PRELIMINARY FISCAL YEAR 2023 NET SALES
IN
RANGE OF $338 MILLION TO $339 MILLION
* ANGIODYNAMICS INC - TRANSACTION WILL BE DILUTIVE TO
ADJUSTED
EARNINGS PER SHARE AND IS EXPECTED TO BE SLIGHTLY DILUTIVE TO
CORPORATE GROSS MARGINS
Source text for Eikon: ID:nBw9fxd6Ma
Further company coverage: ANGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merit Medical Systems
See all newsMerit Medical Systems Inc reports results for the quarter ended March 31 - Earnings Summary
Merit Medical Q2 adjusted EPS beats estimates, raises 2026 outlook
Brief: Merit Medical Systems Q2 Adjusted EPS USD 1.19 Vs. IBES Estimate USD 0.96
Brief: Merit Medical Shareholders Elect Scott R. Ward To Board Of Directors
Merit Medical Q1 adjusted EPS rises on therapeutic, foundational growth